Skip to content

The effect of Low-dose aspirin on cervical length as an indicator of preterm delivery in nulliparous pregnant women that has been referred to gynecology clinic in Semnan

The effect of Low-dose aspirin on cervical length as an indicator of preterm delivery in nulliparous pregnant women that has been referred to gynecology clinic in Semnan

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017052825732N15
Enrollment
60
Registered
2017-06-01
Start date
2016-10-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm labour. Preterm labour without delivery

Interventions

Intervention 1: Interventions group: 80 mg of aspirin daily (bedtime) in combination with folic acid + iron tablets from the second trimmest will be prescribed to patients To apply rigorous random as
Treatment - Drugs
Interventions group: 80 mg of aspirin daily (bedtime) in combination with folic acid + iron tablets from the second trimmest will be prescribed to patients To apply rigorous random assignment, in th
Controls group: Daily folic acid with placebo (Consisting of sugar and starch that the shape, size and color is quite similar to aspirin) + iron tablets will be prescribed to patients.

Sponsors

Vice Chancellor for Research and Technology, Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age between 18 to 40 years; nulliparous; the singleton pregnancy is between 12 to 13 weeks of pregnancy that is confirmed to medical ultrasound; less than 2 miscarriage in the first 3 months of pregnancy. Exclusion criteria: history of loss pregnancy in second trimester; contraindication of aspirin usage; smoking and drugs usage; multiple pregnancy; visible fetal anomalies by medical ultrasound; hemoglobin level less than 7 milligram per deciliter; previous risk of systemic diseases; individuals with short cervical length less than 25 millimeter; uterine anomalies.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Measurement of cervical length. Timepoint: Week 13 and week 30 of pregnancy. Method of measurement: Transvaginal ultrasound.;Blood hemoglobin. Timepoint: Week 13 and week 30 of pregnancy. Method of measurement: Complete Blood Counter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMozhgan Rahmanian

Semnan University of Medical Sciences

are20935@gmail.com+98 23 3345 1336

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026